Dr. Hyman B. Muss discusses the unique facets of care that should inform personalized treatment decision-making for older ...

Mary Anderson’s lifelong commitment to innovation, education and advocacy improves the lives of patients and empowers her ...

I have worked alongside Carmela Cuccurullo, NP.

Dr. Andrew M. Evens breaks down what it means to be an adolescent or young adult with lymphoma and how treatment differs from ...

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends.

For Melanoma Awareness Month, Dr. Douglas Johnson explains how stage and features of the disease can guide treatment decisions after diagnosis.

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of ...

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

Dr. Daniel J. Boffa shared how cancer care teams support patients in quitting smoking and how new data may guide improvements ...